Evaluation of Baroreflex Activation Therapy in Patients With Advanced Heart Failure

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

October 15, 2019

Study Completion Date

May 31, 2020

Conditions
Heart Failure
Interventions
DEVICE

Barostim neo implantation

"The Barostim neo Implantation is a new promising treatment option for patients with advanced heart failure (HEFrEF) as it might improve cardiac and vascular function by restoring sympathovagal-balance through its effects on the autonomic nervous system.~In this observational study, data from patients who have received the Barostim neo System as part of clinical routine will be collected and analyzed. The implantation of this new device is not part of the study."

Trial Locations (1)

32545

Herz- und Diabeteszentrum NRW, Bad Oeynhausen

All Listed Sponsors
lead

Heart and Diabetes Center North-Rhine Westfalia

OTHER

NCT03230643 - Evaluation of Baroreflex Activation Therapy in Patients With Advanced Heart Failure | Biotech Hunter | Biotech Hunter